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THE OUTBREAK OF WEST NILE VIRUS INFECTION
IN THE NEW YORK CITY AREA IN 1999
DENIS NASH, PH.D., M.P.H., FARZAD MOSTASHARI, M.D., M.S.P.H., ANNIE FINE, M.D., JAMES MILLER, M.D., M.P.H.,
DANIEL O’LEARY, D.V.M., KRISTY MURRAY, D.V.M., ADA HUANG, M.D., AMY ROSENBERG, M.D., ABBY GREENBERG, M.D.,
MARGARET SHERMAN, R.N., SUSAN WONG, PH.D., AND MARCELLE LAYTON, M.D.,
FOR THE 1999 WEST NILE OUTBREAK RESPONSE WORKING GROUP*

ABSTRACT
Background In late August 1999, an unusual cluster of cases of meningoencephalitis associated with
muscle weakness was reported to the New York City
Department of Health. The initial epidemiologic and
environmental investigations suggested an arboviral
cause.
Methods Active surveillance was implemented to
identify patients hospitalized with viral encephalitis
and meningitis. Cerebrospinal fluid, serum, and tissue specimens from patients with suspected cases
underwent serologic and viral testing for evidence of
arboviral infection.
Results Outbreak surveillance identified 59 patients who were hospitalized with West Nile virus infection in the New York City area during August and
September of 1999. The median age of these patients
was 71 years (range, 5 to 90). The overall attack rate
of clinical West Nile virus infection was at least 6.5
cases per million population, and it increased sharply
with age. Most of the patients (63 percent) had clinical signs of encephalitis; seven patients died (12 percent). Muscle weakness was documented in 27 percent of the patients and flaccid paralysis in 10 percent;
in all of the latter, nerve conduction studies indicated
an axonal polyneuropathy. An age of 75 years or older was an independent risk factor for death (relative
risk adjusted for the presence or absence of diabetes
mellitus, 8.5; 95 percent confidence interval, 1.2 to
59.1), as was the presence of diabetes mellitus (ageadjusted relative risk, 5.1; 95 percent confidence interval, 1.5 to 17.3).
Conclusions This outbreak of West Nile meningoencephalitis in the New York City metropolitan area
represents the first time this virus has been detected
in the Western Hemisphere. Given the subsequent
rapid spread of the virus, physicians along the eastern
seaboard of the United States should consider West
Nile virus infection in the differential diagnosis of encephalitis and viral meningitis during the summer
months, especially in older patients and in those with
muscle weakness. (N Engl J Med 2001;344:1807-14.)
Copyright © 2001 Massachusetts Medical Society.

I

N late August 1999, a specialist in infectious
diseases contacted the New York City Department of Health about two patients with encephalitis at a hospital in northern Queens. A preliminary epidemiologic investigation at the nearby
hospitals identified six additional cases of encephalitis. These eight cases occurred among previously
healthy persons 58 to 87 years of age1 who presented with a febrile illness followed by changes in mental status. All but one had severe muscle weakness.
Four had flaccid paralysis requiring ventilatory support, and three were thought to have atypical Guillain–Barré syndrome.2,3 Hematologic and biochemical
tests of patients’ cerebrospinal fluid suggested viral
infection as the cause.
The eight patients with encephalitis all lived in a
41.6 km 2 (16 mi 2) area in northern Queens. Interviews with the patients’ families revealed no obvious
common exposures. However, all patients had reportedly engaged in outdoor activities (e.g., gardening)
around their homes in the evenings. An environmental investigation revealed the presence of culex mosquito breeding sites and larvae in many of the patients’ yards and neighborhoods. On the basis of these
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findings, an arthropod-borne virus (arbovirus) was
suspected as the cause of this cluster of cases of encephalitis.
When specimens were tested for arboviruses that
are common in eastern North America, specimens
from all eight patients had positive results on enzymelinked immunosorbent assay (ELISA) for IgM antibody against St. Louis encephalitis virus, a common
flavivirus that is enzootic in North America. The laboratory, clinical, and epidemiologic data indicated that
the outbreak in New York City was most consistent
with an outbreak of St. Louis encephalitis, and mosquito-control measures were instituted rapidly.1,4,5
Before and during the investigation of the encephalitis cluster, an epizootic disease associated with the
death of substantial numbers of birds was occurring
in the New York City area. These deaths were initially
assumed to be unrelated to the outbreak in humans,
because St. Louis encephalitis virus does not normally kill its avian reservoir hosts. An independent
investigation of dead birds by veterinarians and wildlife
specialists in September found pathological evidence
of multiorgan involvement, including encephalitis, but
specimens obtained at necropsy tested negative for
common avian pathogens. Four weeks after the recognition of the outbreak in humans, a flavivirus, later
identified as West Nile virus, was isolated from tissue
specimens obtained from American crows in Westchester County and a Chilean flamingo in a nearby
zoo6 and was subsequently determined to be the common cause of the encephalitis outbreaks among both
birds and humans.7,8
West Nile virus belongs to the Japanese encephalitis serogroup of flaviviruses that includes the St.
Louis encephalitis, Kunjin, and Murray Valley encephalitis viruses, each of which is antigenically closely related to West Nile virus.9 This report summarizes the findings of an epidemiologic investigation of
the 1999 outbreak of West Nile virus disease in the
New York City metropolitan area, which was the first
documented occurrence of this virus in the Western
Hemisphere.
METHODS

In addition, active surveillance to identify patients who met the
clinical criteria included weekly telephone inquiries to adult and
pediatric clinical staff in up to nine specialty areas (e.g., infectious
disease and neurology) at each hospital. Specimens of cerebrospinal
fluid and serum were requested from patients who met the clinical criteria. A serum specimen obtained during the convalescent
phase was requested if an initial specimen, which had been obtained within eight days after the onset of illness from any patient
who met the clinical criteria, tested negative for antibodies against
West Nile virus. For patients who had been discharged, serum samples from the convalescent phase were obtained during home visits.
Laboratory Methods
Samples of serum and cerebrospinal fluid were tested with an
IgM-capture ELISA and an indirect IgG ELISA for antibodies
against the West Nile and St. Louis encephalitis viruses.10,11 In addition, specimens of cerebrospinal fluid and tissue were tested by
standard reverse-transcriptase polymerase chain reaction (RT-PCR)
and real-time RT-PCR (TaqMan, PE Applied Biosystems, Foster
City, Calif.)12; we also attempted to isolate virus from clinical specimens and conducted immunohistochemical analysis of them.13
Definitions
The finding of any of the following was considered to represent
laboratory evidence of recent infection with West Nile virus14: the
isolation by culture of West Nile virus or the amplification by RTPCR of West Nile virus RNA from human-tissue specimens; the
demonstration of IgM antibodies against West Nile virus in cerebrospinal fluid by IgM-capture ELISA; an increase by more than
a factor of four in the titer of neutralizing antibody specific for
West Nile virus, as measured by the plaque-reduction neutralization assay in paired serum or cerebrospinal fluid samples obtained
at appropriate times; or the detection in a single serum specimen of
both IgM and IgG antibodies against West Nile virus on ELISA
(and, for IgG, confirmed by a plaque-reduction neutralization assay). Patients with a single serum sample in which only IgM antibodies to West Nile virus were detected were classified as having
a probable recent infection. Patients with a single serum specimen
in which only IgG antibodies to West Nile virus were detected
were also classified as having a probable recent West Nile virus infection acquired in the New York area if the antibodies were confirmed by plaque-reduction neutralization assay to be specific to
West Nile virus and if the patient had no history of recent travel to
an area where the virus was endemic.
Patients were classified as having hypertension, diabetes mellitus, coronary artery disease, alcoholism, or immunosuppression if
a history of these conditions was noted in their medical record.
Patients were also classified as having a history of immunosuppression if any of the following conditions were present: cancer, human immunodeficiency virus (HIV) infection, treatment with corticosteroids, or alcoholism. Patients with encephalitis were classified
as having muscle weakness if neurologic examinations revealed
flaccid paralysis, decreased strength, or hyporeflexia.
Collection and Analysis of Epidemiologic and Clinical Data

Surveillance Methods
Hospitals in New York City and neighboring counties were
asked to report any suspected cases of viral infections of the central nervous system. Counties were asked, through weekly broadcast-facsimile alerts, to report all suspected cases. Patients with suspected cases were defined as those who were hospitalized on or
after August 1, 1999, with a presumptive diagnosis of viral encephalitis (indicated by fever, altered mental status or other cortical
signs, and abnormal findings on analysis of cerebrospinal fluid),
aseptic meningitis (fever, meningeal signs, and abnormal findings
on analysis of cerebrospinal fluid), or Guillain–Barré syndrome
associated with fever. The abnormal findings in cerebrospinal fluid
that were considered to be indicative of a viral infection were a
protein concentration of at least 40 mg per deciliter or a whitecell count of at least 5 per cubic millimeter, a negative Gram’s
stain, and a negative bacterial culture.

Interviews were conducted with the patients or their proxies to
ascertain the epidemiologic and demographic risk factors for arboviral infection. The medical records of all hospitalized patients
with laboratory evidence of West Nile virus infection were reviewed
with the use of a standardized form for abstracting information from
medical charts. If a sign or symptom was not specifically noted in
the medical record, it was considered to be absent.
The attack rates of West Nile virus disease per million population,
stratified according to age and borough or county, were calculated with the use of 1990 U.S. Census data.15 The crude relative risks
and the relative risks adjusted according to the Mantel–Haenszel
method were calculated to examine the associations of age, history of immunosuppression, and the presence or absence of coronary artery disease, diabetes, or hypertension with the severity of
disease and mortality. Statistical analyses were performed with the
use of SAS software for Windows and Macintosh.16,17
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RESULTS
Arboviral Outbreak Surveillance

Reports on 719 patients with clinical syndromes
of meningitis and encephalitis were received by the
health departments in New York City (589 patients),
Nassau County (70 patients), and Westchester County (60 patients), including 71 patients younger than
18 years old. In 62 of these 719 patients (9 percent),
there was laboratory evidence of recent West Nile virus infection. Three of these patients had a mild illness, with symptoms that consisted of only fever and
headache, which did not result in hospitalization. This
report focuses on the 59 hospitalized patients with
West Nile virus infection.
Cerebrospinal fluid specimens were available from
32 of the 59 patients: 30 of these (94 percent) were
positive for IgM antibodies against West Nile virus.
Serum specimens were also obtained from 29 of the
30 patients with IgM-positive cerebrospinal fluid specimens; all of these serum specimens were IgM-positive. The two patients with IgM-negative cerebrospinal
fluid specimens had IgM-positive serum specimens.
Of the 19 cerebrospinal fluid specimens that were
obtained from patients within eight days after the onset of illness, 17 (89 percent) were positive for IgM
antibodies against West Nile virus.
For 27 of the patients, no cerebrospinal fluid specimen was available; viral infection in these patients
was confirmed on the basis of the finding of IgM antibodies in the serum. The serologic diagnosis in patients from whom no cerebrospinal fluid specimens
had been obtained was confirmed by plaque-reduction neutralization assay. No cases were positive by
isolation of virus from brain tissue or cerebrospinal
fluid specimens. Among the specimens with sufficient
quantity to allow for real-time RT-PCR testing, 16
of 28 cerebrospinal fluid specimens (57 percent) and
4 of 28 serum specimens (14 percent) were positive
for West Nile virus genome. In all the patients who
died in whom autopsies were performed, the brain
tissue was positive for West Nile virus antigen on immunohistochemical analysis, and positive for West Nile
virus genome on real-time RT-PCR.
Epidemiologic Characteristics

The median age of the hospitalized patients was
71 years (range, 5 to 90), and most of them (88 percent) were at least 50 years old (Table 1). The overall
attack rate of clinical West Nile virus infection was at
least 6.5 cases per million population. The most cases (32) and the highest rate of hospitalization (16.4
per million population) occurred in the New York
City borough of Queens. The onset of illness ranged
from August 2 through September 24, 1999 (Fig. 1),
with the peak of the outbreak occurring in mid-tolate August. The attack rate of clinical infection increased sharply with age, and the attack rate in per-

sons 50 years old or older was almost 20 times as
high as that in persons younger than 50 years old (rate
ratio, 19.6; 95 percent confidence interval, 17.9 to
21.6). Of the 59 hospitalized patients, 44 resided in
New York City, 14 lived in two adjacent counties of
New York state, and 1 was a tourist from Canada who
arrived in New York City on September 1, departed
on September 5 after visiting Queens, and became
ill on the airplane (which suggests an incubation period of less than five days).
Interviews were completed with 56 of the 59 patients (95 percent). Only three (5 percent) reported
having traveled outside the United States (to Aruba,
St. Martin, and Canada) during the month before the
onset of illness. Only 18 patients (32 percent) recalled being bitten by mosquitoes during the month
before the onset of illness.
Clinical Characteristics

Of the 59 patients, 37 (63 percent) had encephalitis, 17 (29 percent) had meningitis without encephalitis, and 5 (8 percent) had illness characterized by
fever and headache (Table 2). The mean duration of
symptoms before hospitalization was 5.3 days. Nearly all the patients presented with fever (90 percent;
temperature range, 36.5°C to 40.2°C); other symptoms included weakness (56 percent), nausea (53 percent), vomiting (51 percent), headache (47 percent),
altered mental status (46 percent), and stiff neck (19
percent). A rash was reported in 11 patients (19 percent) and was described as an erythematous macular,
papular, or morbilliform eruption involving some
combination of the neck, the trunk, and the arms
and legs.
Underlying chronic medical conditions included hypertension (in 42 percent of the patients), diabetes
mellitus (in 20 percent), coronary artery disease (in 20
percent), and a history of known immunosuppression
(in 14 percent) (Table 2). The immunosuppression was
caused by cancer (in five patients), HIV infection18 (in
one patient), the use of prednisone for asthma (in one
patient), and alcoholism (in one patient).
Complete blood counts on admission showed no
substantial abnormalities (Table 3). However, the
cerebrospinal fluid findings were typical of a viral infection: pleocytosis (mean cerebrospinal fluid whitecell count, 38.2 per cubic millimeter; range, 0 to 525)
and an elevated protein concentration (mean, 104.2
mg per deciliter; range, 38 to 899).
Computed tomographic scans of the brain were
obtained for 43 patients (73 percent); they showed
no evidence of acute disease (Table 4). Magnetic resonance imaging of the brain was performed in 16
patients (27 percent); in 5 of these patients (31 percent), the scans showed an enhancement of the leptomeninges, the periventricular areas, or both.
Muscle involvement was documented by neurologic examination as decreased muscle strength (in 27
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TABLE 1. DEMOGRAPHIC CHARACTERISTICS OF 59 PATIENTS HOSPITALIZED
WITH WEST NILE VIRUS INFECTION IN THE NEW YORK CITY AREA IN 1999
AND POPULATION ATTACK RATES.

CHARACTERISTIC

Age (yr)
0–19‡
20–29
30–39
40–49
50–59
60–69
70–79
»80
Age category (yr)
»50
<50‡
Sex
Male
Female‡
Race
White
Nonwhite‡
Unknown
Borough or county of residence
New York City
Brooklyn (Kings)‡
Bronx
Manhattan
Queens
Staten Island (Richmond)
New York State
Nassau
Westchester

NO. OF
PATIENTS
(%)

POPULATION
AT RISK*

RATE OF INFECTION
PER MILLION
POPULATION

2
1
3
1
9
13
18
12

(3)
(2)
(5)
(2)
(15)
(22)
(31)
(20)

2,324,081
1,553,981
1,549,111
1,177,190
867,331
814,838
534,785
281,054

0.9
0.6
1.9
0.8
10.4
16.0
33.7
42.7

1.0
0.8
2.3
1.0
12.1
18.5
39.1
49.6

52 (88)
7 (12)

2,498,008
6,604,363

20.8
1.1

19.6 (17.9–21.6)
1.0

31 (53)
28 (47)

4,289,988
4,812,383

7.2
5.8

1.2 (1.0–1.6)
1.0

41 (69)
9 (15)
9 (15)

5,983,901
3,118,470
—

6.9
2.9
—

2.4 (1.3–4.4)
1.0

3
9
1
32
0

2,300,664
1,203,789
1,487,536
1,951,599
379,999

1.3
7.5
0.7
16.4
0.0

1.0
5.7 (4.1–8.0)
0.5 (0.1–2.8)
12.6 (11.4–13.9)
—

1,287,348
874,866

4.7
9.1

3.6 (2.3–5.7)
7.0 (4.9–10.1)

(5)
(15)
(2)
(54)§

6 (10)
8 (14)

RATE RATIO
(95% CI)†

(0.2–3.7)
(1.1–4.6)
(0.2–4.9)
(9.1–15.9)
(15.2–22.6)
(33.8–45.3)
(40.1–61.5)

*Population figures are from the 1990 U.S. Census.
†CI denotes confidence interval.
‡This group served as the reference population.
§This group includes a Canadian tourist who became ill after visiting relatives in Queens.

percent of patients) and hyporeflexia (in 32 percent)
and was more common among the patients with encephalitis. Diffuse, flaccid paralysis occurred in 10
percent of the patients, with no discernible ascending or descending pattern of progression. Abnormal
findings consistent with an axonal polyneuropathy
were noted in 8 of the 10 patients who underwent
electrophysiologic testing, with decreased nerve conduction velocity of motor or sensory nerves or both
and diminished compound muscle action potentials
and fibrillation potentials on electromyography.
Among the 589 patients with suspected West Nile
virus infection reported in New York City, those with
encephalitis accompanied by muscle weakness were
more likely to be seropositive for West Nile virus (27
percent) than were patients with encephalitis alone
(14 percent) or aseptic meningitis (6 percent) (P for
trend <0.001).

and death are shown in Table 5. Only an age of 75
years or older was associated with a significantly higher likelihood of having encephalitis with muscle weakness (relative risk, 2.7; 95 percent confidence interval,
1.3 to 5.8). Of the 59 patients, 7 died, for an overall
case fatality rate of 12 percent. Among the patients
with encephalitis who also had muscle weakness, the
case fatality rate was 30 percent, with six of the seven deaths occurring in patients with encephalitis and
muscle weakness. An age of 75 years or older was the
factor most strongly associated with death (relative
risk adjusted for the presence or absence of diabetes
mellitus, 8.5; 95 percent confidence interval, 1.2 to
59.1). The presence of diabetes mellitus was also significantly associated with death, even after adjustment
for age (age-adjusted relative risk, 5.1; 95 percent
confidence interval, 1.5 to 17.3).

Factors Predictive of Disease Severity and Prognosis

Autopsy reports on the four patients from New
York City who died, as well as immunohistochemical
analysis of cortical tissue, showed only minimal evi-

The analyses of potential risk factors for severe
disease (defined as encephalitis with muscle weakness)

Pathological Findings
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20
TABLE 2. CLINICAL CHARACTERISTICS OF 59 PATIENTS
HOSPITALIZED WITH WEST NILE VIRUS INFECTION
IN THE NEW YORK CITY AREA IN 1999.
NO. OF
PATIENTS (%)

CHARACTERISTIC

;
;;;;;;;;
;;; ; ;;

15

No. of Cases

New York StateI
New York City

10

5

Ju
ly

25
–3
A
ug 1
.1
A
ug –7
.8
A
ug –1
.1 4
5–
A
u
2
A
ug g. 2 1
2–
.2
28
9–
Se
p
Se
t
pt . 4
.
Se 5–
pt
11
.
Se 12–
1
pt
.1 8
9–
25

0

Syndromes
Encephalitis
With weakness
Without weakness
Aseptic meningitis without encephalitis
Fever and headache

20
17
17
5

(34)
(29)
(29)
(8)

Signs and symptoms
Fever (temperature >37.8°C)
Weakness
Nausea
Vomiting
Headache
Altered mental status
Diarrhea
Rash
Cough
Stiff neck
Myalgia
Arthralgia
Photophobia
Tremor
Slurred speech
Abdominal pain
Focal sensory change
Pharyngitis
Conjunctivitis
Seizures
Lymphadenopathy

53
33
31
30
28
27
16
11
11
11
10
9
8
7
5
4
4
3
2
2
1

(90)
(56)
(53)
(51)
(47)
(46)
(27)
(19)
(19)
(19)
(17)
(15)
(14)
(12)
(8)
(7)
(7)
(5)
(3)
(3)
(2)

Medical history
Hypertension
Diabetes
Coronary artery disease
Known immunosuppression
Dementia
Head trauma

25
12
12
8
3
2

(42)
(20)
(20)
(14)
(5)
(3)

Week of Onset of Illness

Figure 1. Numbers of Patients Hospitalized with West Nile Virus
Infection (Epidemic Curve) in the New York City Metropolitan
Area in 1999.
Hatched boxes represent patients who resided in New York
City, and light gray boxes represent patients who resided in
other parts of New York State.

TABLE 3. SELECTED LABORATORY RESULTS FOR 59 PATIENTS
HOSPITALIZED WITH WEST NILE VIRUS INFECTION
IN THE NEW YORK CITY AREA IN 1999.

VARIABLE

dence of viral inflammation in brain tissue.13 Evidence of West Nile virus infection was more likely to
be found in the brain stem than in other sites in the
brain or in extraneural tissue. In the most severe case,
there was evidence of scattered microglial nodules;
perivascular and perineuronal inflammation, primarily confined to the medulla and the cranial-nerve
roots, was also present.19 One patient was found on
postmortem examination to have hemorrhagic pancreatitis. Autopsy did not reveal evidence of hepatitis
or myocarditis.

MEAN ±SD

RANGE

Blood
2.3–30.8
White-cell count (¬10¡3/mm3) 10.4±4.9
Hemoglobin (g/dl)
13.5±1.7
9.0–16.7
Hematocrit (%)
39.1±6.0
10.2–50.2
Lymphocytes (%)
14.1±7.3
3.0–38.0
Cerebrospinal fluid
Interval between onset and
9.3±7.2
0–24
collection (days)
Protein (mg/dl)
104.2±117.2 38.0–899.0
38.2±11.6
0–525
White-cell count (per mm3)
Lymphocytes (%)
47.4±29.0
4.0–92.0
Glucose (mg/dl)
79.8±20.9 46.0–143.0

NORMAL
RANGE

3.2–9.8
11.5–18.0
33.0–49.0
>25.0
—
15.0–50.0
0–10
63.0–99.0
40.0–80.0
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TABLE 4. HOSPITAL COURSE IN 59 PATIENTS WITH WEST NILE
VIRUS INFECTION IN THE NEW YORK CITY AREA IN 1999,
ACCORDING TO CLINICAL PRESENTATION.*
PATIENTS
WITH

PATIENTS
ALL
PATIENTS
(N=59)

VARIABLE

WITH

ENCEPHALITIS
(N=37)

MENINGITIS
OR OTHER
SYMPTOMS
(N=22)

no./total no. (%)

CT scanning results
Normal
Atrophy or ischemic changes
Evidence of acute disease
MRI results
Normal
Atrophy or ischemic changes
Meningeal enhancement
Abnormal cranial nerve function
Motor examination findings
Abnormal strength
Flaccid paralysis
Abnormal deep tendon reflexes
Hyporeflexia
Hyperreflexia
Electromyelography and nerve
conduction study results
Axonal neuropathy
Admitted to intensive care unit
Respiratory symptoms
Required oxygen
Required mechanical ventilation
Treatments
Plasmapheresis
Intravenous immune globulin
Antibiotics
Acyclovir

27/43 (63) 16/31 (52) 11/12 (92)
16/43 (37) 15/31 (48) 1/12 (8)
0/43
0/31
0/12
5/16
6/16
5/16
13/59

(31) 5/13
(38) 4/13
(31) 4/13
(22) 11/37

(38)
(31)
(31)
(30)

16/59
6/59
23/59
19/23
4/23

(27) 12/37 (32)
(10) 4/37 (11)
(39) 16/37 (43)
(83) 15/16 (94)
(17) 1/16 (6)

0/3
2/3 (67)
1/3 (33)
2/22 (9)
4/22
2/22
7/22
4/7
3/7

(18)
(9)
(32)
(57)
(43)

8/10 (80) 5/6 (83)
19/59 (32) 16/37 (43)

3/4 (75)
3/22 (14)

19/59 (32) 15/37 (41)
10/59 (17) 9/37 (24)

4/22 (18)
1/22 (5)

3/59
1/59
51/59
24/59

(5)
2/37 (5)
1/22 (5)
(2)
1/37 (3)
0/22
(86) 36/37 (97) 15/22 (68)
(41) 21/37 (57) 3/22 (14)
days

Length of hospitalization
Mean
Range

14.8
0–82

17.9
0–82

12.4
3–56

*CT denotes computed tomographic, and MRI magnetic resonance imaging. The denominators for CT scanning results, MRI results, and electromyelography and nerve conduction study results represent the numbers
of patients who underwent those tests. Hyporeflexia and hyperreflexia are
subcategories of abnormal deep-tendon reflexes.

DISCUSSION

West Nile virus is enzootic in Africa, Europe, and
Asia. Its typical reservoirs include a wide variety of
wild and domestic birds, and the vectors are mosquitoes of the culex species.20 Most West Nile virus infections in humans are subclinical, with overt disease
estimated to occur in approximately 1 of every 100
infections.21 The incubation period ranges from 3 to
15 days.22 The resulting illness varies from mild illness (with fever, petechial rash, and headache) to
meningoencephalitis,9 and the likelihood that severe
neurologic illness will develop increases with age.23
Underlying medical conditions (e.g., hypertension)
may facilitate the passage of neurotropic flaviviruses
across the blood–brain barrier and may predispose

infected persons to neurologic complications.24-27 In
previous outbreaks, the case fatality rate among clinical cases ranged from 4 percent to 13 percent and
was highest among elderly persons.20
This outbreak represents the first recognized occurrence of West Nile virus in the Western Hemisphere. In areas where it is endemic, West Nile virus
usually causes outbreaks of milder febrile illness.9,28,29
The 1999 outbreak in the New York City area followed a pattern more characteristic of recent outbreaks of encephalitis in areas where the virus is not
endemic and where the level of immunity of the population to West Nile virus is lower (e.g., Romania
and Russia); in these outbreaks, recognized illness was
characterized by severe neurologic disease that affected primarily older adults.20,30-34 Genetic analysis
indicated that the strain of West Nile virus responsible for this outbreak was similar to strains that have
caused outbreaks of encephalitis in northern Europe
and was nearly identical to a strain that was circulating in Israel in 1998.7
In our study, older age was associated with a substantially higher risk of more severe neurologic disease, and both age and the presence of diabetes mellitus were significant risk factors for death. Decreasing
immunity is a consequence of aging as well as a complication of diabetes mellitus, and both factors can
increase the host’s susceptibility to infections.35-38 The
relation we found between diabetes and the fatal outcome of West Nile virus infections requires further
study.
The outbreak in the New York City area was unusual because profound muscle weakness was a common complication in the patients with encephalitis.
This unusual finding of profound muscle weakness
prompted the initial report of a cluster of cases of encephalitis to the New York City Department of Health
and ultimately led to the recognition of a regional epidemic and epizootic of West Nile virus infection.
Most of the mosquito pools that tested positive
for West Nile virus by RT-PCR and real-time RT-PCR
and from which virus could be isolated contained
both Culex pipiens and C. restuans mosquitoes39;
such pools were found in all the areas where cases
occurred among humans except Manhattan. However, West Nile virus infection in birds was much
more geographically widespread than indicated by
the distribution of the human cases and positive mosquito pools.40 Infected dead crows were found in areas where no human cases were detected, including
the lower Hudson Valley, eastern Long Island, Connecticut, New Jersey, and Baltimore. Serologic studies conducted in live wild birds in September 1999
demonstrated a direct geographic correlation between
the rates of West Nile meningoencephalitis in humans
and the prevalence of antibody against West Nile virus in birds that were tested in Queens (avian seroprevalence, 50 percent), Westchester County (11 per-
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TABLE 5. RELATIVE RISKS OF MUSCLE WEAKNESS, ENCEPHALITIS WITH MUSCLE
WEAKNESS, AND DEATH ASSOCIATED WITH VARIOUS PROGNOSTIC FACTORS
IN 59 PATIENTS HOSPITALIZED WITH WEST NILE VIRUS INFECTION.*
FACTOR

RELATIVE RISK (95% CONFIDENCE INTERVAL)

Known history of immunosuppression
Coronary artery disease
Hypertension
Diabetes mellitus
Age »75 yr
Unadjusted
Adjusted for presence or absence
of diabetes mellitus
Muscle weakness
Virus detected by PCR in cerebrospinal fluid†

MUSCLE

ENCEPHALITIS WITH

WEAKNESS

MUSCLE WEAKNESS

1.6
1.2
1.6
1.0

(1.0–2.6)
(0.5–2.6)
(0.9–2.5)
(0.5–1.9)

1.4
1.4
1.2
1.3

(0.4–11.1)
(0.7–2.6)
(0.6–2.3)
(0.6–2.7)

DEATH

2.1
2.0
2.1
5.1

(0.5–8.1)
(0.6–6.6)
(0.3–12.2)
(1.5–17.3)

1.4 (0.8–2.3)
1.4 (0.8–2.3)

2.7 (1.3–5.8)
2.4 (1.3–4.6)

8.8 (1.1–68.1)
8.5 (1.2–59.1)

—
0.7 (0.3–1.8)

—
2.3 (0.6–9.0)

4.6 (0.7–31.6)
1.0 (0.2–5.0)

*Muscle weakness was defined by evidence of flaccid paralysis, abnormal strength, or hyporeflexia
on neurologic examination. The relative risks associated with a history of immunosuppression and
with the presence of coronary artery disease, hypertension, and diabetes mellitus have been adjusted
for age. PCR denotes polymerase chain reaction.
†Specimens of cerebrospinal fluid from 25 patients were available for testing by real-time reversetranscriptase PCR.

cent), Nassau County (7 percent), Brooklyn (5 percent), and Staten Island (2 percent).41
Recent data suggest that West Nile virus has become enzootic in the northeastern United States. In
the winter after the 1999 outbreak, West Nile virus
was isolated from overwintering culex mosquitoes
collected in Queens.42,43 Surveillance of birds and
mosquitoes during 2000 showed extensive epizootic
activity centered in the New York City metropolitan
area and extending throughout much of the eastern
seaboard, with reports of dead birds that tested positive for West Nile virus from southern Vermont and
New Hampshire down to North Carolina. However,
a human outbreak of meningoencephalitis during the
late summer and early fall of 2000 was limited to New
York City (14 cases) and New Jersey (5 cases).43,44
West Nile virus will most likely spread beyond the
northeast and may cause sporadic cases or outbreaks
of West Nile virus disease in other regions of the
United States. During the mosquito season (from late
spring until the first sustained frost), physicians —
especially those along the eastern seaboard — should
consider West Nile virus disease in the differential
diagnosis of hospitalized patients with encephalitis
(especially when it is accompanied by muscle weakness) and viral meningitis (especially in adults).43 Serologic testing remains the most reliable diagnostic
method for West Nile virus infection in humans. Suspected cases should be reported to local public health
departments, and appropriate laboratory specimens,
including cerebrospinal fluid and serum samples ob-

tained during the acute and convalescent phases, as
well as autopsy specimens, should be submitted to
state public health laboratories to be tested for West
Nile virus. Treatment is supportive.
The 1999 West Nile virus disease outbreak again
proves that, with the growing volume of international
travel and commerce, exotic pathogens can move between continents with increasing ease. Physicians, veterinarians, laboratory workers, and public health officials must remain vigilant for unexpected outbreaks
of imported diseases in the future.
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